4.7 Article

Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep-wake Disturbances in AD Mice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Neurosciences

Alzheimer's disease - the journey of a healthy brain into organ failure

Todd E. Golde

Summary: As the most common form of dementia, Alzheimer's disease (AD) has a significant impact on individuals, society, and the economy. While we have made progress in understanding the mechanisms underlying AD pathogenesis and diagnosing the disease, there are still many gaps in our knowledge. AD is not solely a disease of aging, as both heritable and non-heritable factors can influence the risk of developing the disease. In order to change how AD is perceived and managed, we need to address these knowledge gaps, develop more effective therapies, and intervene at the appropriate stage of the disease.

MOLECULAR NEURODEGENERATION (2022)

Article Multidisciplinary Sciences

BACE-1 inhibition facilitates the transition from homeostatic microglia to DAM-1

Neeraj Singh et al.

Summary: BACE-1 plays a role in regulating the transition of microglia in Alzheimer's disease. Deficiency of BACE-1 leads to increased expression of certain transcription factors involved in the transition from homeostatic to highly phagocytic microglia. Similar transition-state microglia in AD brains are associated with decreased levels of BACE-1 expression.

SCIENCE ADVANCES (2022)

Article Multidisciplinary Sciences

Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance

Neeraj Singh et al.

Summary: This study demonstrates that targeted inhibition of BACE-1 in microglia has unique advantages in the treatment of Alzheimer's disease, including reducing amyloid plaque formation, enhancing Aβ clearance, and promoting the functions of autophagolysosomes and Aβ-induced metabolic reprogramming.

SCIENCE ADVANCES (2022)

Review Neurosciences

Microglial TYROBP/DAP12 in Alzheimer's disease: Transduction of physiological and pathological signals across TREM2

Jean-Vianney Haure-Mirande et al.

Summary: TYROBP plays a critical role in the function of microglia and signaling of receptors related to diseases like Alzheimer's. TYROBP deficiency prevents the accumulation of C1q and may affect the neuropathological features associated with clinical cognitive function.

MOLECULAR NEURODEGENERATION (2022)

Review Neurosciences

The β-Secretase BACE1 in Alzheimer's Disease

Harald Hampel et al.

Summary: BACE1 is a well-validated therapeutic target for slowing down Aβ production in early AD, despite previous clinical trials being discontinued. Further research should focus on the roles of BACE1 and Aβ in physiological and pathophysiological processes, as well as the substrates and downstream effects of BACE1 and BACE2.

BIOLOGICAL PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide

Kaori Sato et al.

Summary: The study created a new AD mouse model by introducing the Psen1P117L/WT mutation into the AppNL-F mouse line, showing more cored plaque pathology and neuroinflammation than AppNL-G-F mice. This new third-generation mouse model will help accelerate the development of disease-modifying therapies for preclinical AD.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Neurosciences

Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia

Diana P. Benitez et al.

Summary: The study found that microglial response to increased amyloid beta levels is delayed, with an increase in glutamate release probability observed in knock-in and transgenic mouse models of Alzheimer's disease. The findings suggest that alterations in surviving phagocytic microglia, rather than microglial loss, may play a role in age-dependent effects on glutamate release, which become exacerbated in Alzheimer's disease.

MOLECULAR NEURODEGENERATION (2021)

Article Clinical Neurology

The case for low-level BACE1 inhibition for the prevention of Alzheimer disease

Eric McDade et al.

Summary: All phase III trials of BACE inhibitors for Alzheimer disease have been discontinued or produced negative results. However, the authors believe that BACE inhibitors still hold promise as a preventative therapy for AD and suggest a series of experiments to inform future trials. The authors also discuss the status of BACE inhibitors and propose ways in which the results of discontinued trials can inform the development of future clinical trials.

NATURE REVIEWS NEUROLOGY (2021)

Review Biochemistry & Molecular Biology

The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway

Aleksandra Deczkowska et al.

Article Clinical Neurology

Seizures in Alzheimer's disease are highly recurrent and associated with a poor disease course

Jonathan Voeglein et al.

JOURNAL OF NEUROLOGY (2020)

Review Multidisciplinary Sciences

Glymphatic failure as a final common pathway to dementia

Maiken Nedergaard et al.

SCIENCE (2020)

Review Neurosciences

Local Sleep and Alzheimer's Disease Pathophysiology

Bryce A. Mander

FRONTIERS IN NEUROSCIENCE (2020)

Review Clinical Neurology

A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment

Brati Das et al.

CNS DRUGS (2019)

Review Biochemistry & Molecular Biology

Sleep Disturbance as a Potential Modifiable Risk Factor for Alzheimer's Disease

Eiko N. Minakawa et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Clinical Neurology

Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease

Erik S. Musiek et al.

JAMA NEUROLOGY (2018)

Article Multidisciplinary Sciences

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays

Gabriella Panuccio et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)

Article Cell Biology

Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice

Ming-Hsuan Ou-Yang et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Review Clinical Neurology

The glymphatic pathway in neurological disorders

Martin Kaag Rasmussen et al.

LANCET NEUROLOGY (2018)

Review Neurosciences

New insights into the role of TREM2 in Alzheimer's disease

Maud Gratuze et al.

MOLECULAR NEURODEGENERATION (2018)

Review Medicine, Research & Experimental

Microglia in Alzheimer's disease

Heela Sarlus et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Clinical Neurology

Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later

Juho Joutsa et al.

JAMA NEUROLOGY (2017)

Article Multidisciplinary Sciences

The Fall of Sleep K-Complex in Alzheimer Disease

Luigi De Gennaro et al.

SCIENTIFIC REPORTS (2017)

Review Neurosciences

Network abnormalities and interneuron dysfunction in Alzheimer disease

Jorge J. Palop et al.

NATURE REVIEWS NEUROSCIENCE (2016)

Review Multidisciplinary Sciences

Mechanisms linking circadian clocks, sleep, and neurodegeneration

Erik S. Musiek et al.

SCIENCE (2016)

Review Biochemistry & Molecular Biology

Receptors, Ion Channels, and Signaling Mechanisms Underlying Microglial Dynamics

Christian Madry et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Review Clinical Neurology

Neuroinflammation in Alzheimer's disease

Michael T. Heneka et al.

LANCET NEUROLOGY (2015)

Review Biochemistry & Molecular Biology

Sleep, circadian rhythms, and the pathogenesis of Alzheimer Disease

Erik S. Musiek et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2015)

Article Neurosciences

Activation of Neuronal NMDA Receptors Triggers Transient ATP-Mediated Microglial Process Outgrowth

Lasse Dissing-Olesen et al.

JOURNAL OF NEUROSCIENCE (2014)

Article Clinical Neurology

Sleep and Alzheimer disease pathology-a bidirectional relationship

Yo-El S. Ju et al.

NATURE REVIEWS NEUROLOGY (2014)

Review Biochemistry & Molecular Biology

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease

Sang-Sun Yoon et al.

BIOMOLECULES & THERAPEUTICS (2012)

Article Neurosciences

BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration

Xiangyou Hu et al.

JOURNAL OF NEUROSCIENCE (2010)

Review Clinical Neurology

Epilepsy and Cognitive Impairments in Alzheimer Disease

Jorge J. Palop et al.

ARCHIVES OF NEUROLOGY (2009)

Article

Seizures in Alzheimer Disease

Nikolaos Scarmeas et al.

ARCHIVES OF NEUROLOGY (2009)

Article Neurosciences

Binding and Uptake of Aβ1-42 by Primary Human Astrocytes In Vitro

Henrietta M. Nielsen et al.

Article Neurosciences

Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy

Rimante Minkeviciene et al.

JOURNAL OF NEUROSCIENCE (2009)

Article Multidisciplinary Sciences

Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle

Jae-Eun Kang et al.

SCIENCE (2009)

Article Neurosciences

Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance

Tristan Bolmont et al.

JOURNAL OF NEUROSCIENCE (2008)

Article Multidisciplinary Sciences

Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease

Melanie Meyer-Luehmann et al.

NATURE (2008)

Article Biochemistry & Molecular Biology

Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities

Xiangyou Hu et al.

EMBO JOURNAL (2007)

Article Endocrinology & Metabolism

Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system

Robert D. Bell et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)

Article Neurosciences

The P2Y12 receptor regulates microglial activation by extracellular nucleotides

Sharon E. Haynes et al.

NATURE NEUROSCIENCE (2006)

Article Clinical Neurology

Incidence and predictors of seizures in patients with Alzheimer's disease

JC Amatniek et al.

EPILEPSIA (2006)

Article Neurosciences

ATP mediates rapid microglial response to local brain injury in vivo

D Davalos et al.

NATURE NEUROSCIENCE (2005)

Article Multidisciplinary Sciences

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

A Nimmerjahn et al.

SCIENCE (2005)

Article Behavioral Sciences

Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen

R Lalonde et al.

BEHAVIOURAL BRAIN RESEARCH (2005)

Article Neurosciences

Increased seizure threshold and severity in young transgenic CRND8 mice

RA Del Vecchio et al.

NEUROSCIENCE LETTERS (2004)

Review Psychiatry

Sleep and quantitative EEG in neurodegenerative disorders

D Petit et al.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2004)

Review Geriatrics & Gerontology

Seizures in elderly patients with dementia - Epidemiology and management

MF Mendez et al.

DRUGS & AGING (2003)